Drug
Gip1 42 Infusion
Gip1 42 Infusion: highest development phase Not Applicable, developed by Zealand Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Not Applicable
- Developer
- Zealand Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| GIP1-42 infusion NCT03526289 | Not Applicable | Type 2 Diabetes Mellitus |
Latest
No recent events.
Follow Gip1 42 Infusion on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.